Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
139.3 USD | +6.38% | +3.65% | -22.96% |
Financials (USD)
Sales 2024 * | 3.08B | Sales 2025 * | 3.93B | Capitalization | 13.68B |
---|---|---|---|---|---|
Net income 2024 * | -892M | Net income 2025 * | -358M | EV / Sales 2024 * | 3.96 x |
Net cash position 2024 * | 1.48B | Net cash position 2025 * | 1.13B | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-15.3
x | P/E ratio 2025 * |
-40.5
x | Employees | 10,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on BeiGene, Ltd.
1 day | +7.55% | ||
1 week | +5.18% | ||
Current month | -9.85% | ||
1 month | -8.40% | ||
3 months | -13.11% | ||
6 months | -16.44% | ||
Current year | -21.83% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.48% | 4 M€ | -27.92% | ||
1.49% | 0 M€ | 0.00% | - | |
1.39% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 138.9 | +6.11% | 102 138 |
24-04-22 | 130.9 | +1.10% | 152,563 |
24-04-19 | 129.5 | -1.85% | 296,412 |
24-04-18 | 132 | +0.08% | 125,955 |
24-04-17 | 131.9 | -1.63% | 200,058 |
Delayed Quote Nasdaq, April 23, 2024 at 11:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.83% | 13.68B | |
-0.25% | 103B | |
+3.29% | 96.73B | |
+1.83% | 21.31B | |
-15.65% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
+6.27% | 13.44B | |
+23.91% | 10.98B | |
-22.63% | 8.56B |
- Stock Market
- Equities
- BGNE Stock